Aquavit Files Investigation of New Drug for New Botulinum Toxin
Aquavit Pharmaceuticals, Inc. has submitted to the U.S. FDA an Investigation of New Drug package for a new botulinum toxin, DTX-021.
Tag: Aquavit Pharmaceuticals
All
Popular
All
LatestSorry, No Posts Found
All
Latest
Global Alliance for Women Leaders in Aesthetic Plastic Surgery Hosts First In-Person Panel
The Global Alliance for Women Leaders in Aesthetic Plastic Surgery hosted its first in-person panel on September 24 at the 26th ISAPS World Congress in Istanbul, Turkey.
